000 01242 a2200337 4500
005 20250514195558.0
264 0 _c20041222
008 200412s 0 0 eng d
022 _a0344-5704
024 7 _a10.1007/s00280-004-0887-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPeek, Richard M
245 0 0 _aPrevention of colorectal cancer through the use of COX-2 selective inhibitors.
_h[electronic resource]
260 _bCancer chemotherapy and pharmacology
_cSep 2004
300 _aS50-6 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xpharmacology
650 0 4 _aColorectal Neoplasms
_xenzymology
650 0 4 _aCyclooxygenase 2
650 0 4 _aEnzyme Inhibitors
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aIntestinal Polyps
_xdrug therapy
650 0 4 _aIsoenzymes
_xantagonists & inhibitors
650 0 4 _aMembrane Proteins
650 0 4 _aMice
650 0 4 _aProstaglandin-Endoperoxide Synthases
_xmetabolism
650 0 4 _aRisk
773 0 _tCancer chemotherapy and pharmacology
_gvol. 54 Suppl 1
_gp. S50-6
856 4 0 _uhttps://doi.org/10.1007/s00280-004-0887-x
_zAvailable from publisher's website
999 _c15008717
_d15008717